Table 2.
Animal studies: agents and model used in relation to the presented effect.
| Impaired bone healing | |
|---|---|
| (1) Aspirin [84] | |
| (2) Celecoxib [101, 102] | |
| (3) Diclofenac [97–99] | |
| (4) Etodolac [104, 105] | |
| (5) Ibuprofen [88, 94–96, 127] | |
| (6) Indomethacin [78–91, 119, 127] | |
| (7) Ketoprofen [77] | |
| (8) Ketorolac [74–76, 107] | |
| (9) Meloxicam [85, 103] | |
| (10) Naproxen [92, 93] | |
| (11) Parecoxib [74] | |
| (12) Rofecoxib [92, 94, 95, 108, 109] | |
| (13) Tenoxicam [99, 100] | |
| (14) Valdecoxib [107] | |
|
| |
| No effect | |
| (1) Celecoxib [80, 111, 119, 120] | |
| (2) Diclofenac [123] | |
| (3) Etoricoxib [110] | |
| (4) Ibuprofen [111, 121, 122] | |
| (5) Indomethacin [81, 111, 114–118] | |
| (6) Ketoprofen [112, 113] | |
| (7) Ketorolac [110, 111] | |
| (8) Meloxicam [113] | |
| (9) Nimesulid [124] | |
| (10) Rofecoxib [111, 123, 125] | |
|
| |
| Short term has no effect | |
| (1) Diclofenac [98, 106] | |
| (2) Ketoprofen [126] | |
| (3) Ketorolac [78] | |
| (4) Parecoxib [106] | |
| (5) Rofecoxib [85, 108] | |
| (6) Valdecoxib [106] | |
|
| |
| Model used | |
| (i) Rats [74, 77, 78, 80, 81, 83, 84, 89–91, 93, 94, 97, 98, 100–107, 110, 114, 116, 118, 121–124, 126] |
|
| (ii) Mouse [109, 111, 120] | |
| (iii) Rabbit [75, 76, 79, 82, 85–88, 92, 95, 96, 99, 108, 112, 115, 119, 125] |
|
| (iv) Dog [117] | |
| (v) Goats [113] | |